erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Hyperhidrosis D006945 2 associated lipids
Jaw Abnormalities D007569 1 associated lipids
Skin Diseases, Vascular D017445 1 associated lipids
Marfan Syndrome D008382 2 associated lipids
Elephantiasis D004604 2 associated lipids
Lymphangitis D008205 4 associated lipids
Gastric Outlet Obstruction D017219 1 associated lipids
Hyperemesis Gravidarum D006939 2 associated lipids
Empyema, Pleural D016724 2 associated lipids
Lymphoma, B-Cell, Marginal Zone D018442 1 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Dimaraki EV and Jaffe CA Troglitazone induces CYP3A4 activity leading to falsely abnormal dexamethasone suppression test. 2003 J. Clin. Endocrinol. Metab. pmid:12843151
Iuliucci RJ et al. Ring-chain tautomerism in solid-phase erythromycin A: evidence by solid-state NMR. 2003 Solid State Nucl Magn Reson pmid:12850255
George RC et al. Antibiotic-resistant pneumococci in the United Kingdom. 1992 Commun Dis Rep CDR Rev pmid:1285099
McGhan LJ and Merchant SN Erythromycin ototoxicity. 2003 Otol. Neurotol. pmid:12851569
Burkhart CN Reassessment of combining benzoyl peroxide with clindamycin. 2002 J Drugs Dermatol pmid:12851984
Thiele J et al. Mixed chimerism of erythro- and megakaryopoiesis following allogeneic bone marrow transplantation. 2003 Acta Haematol. pmid:12853689
Musumeci R et al. Internalization-associated proteins among Streptococcus pyogenes isolated from asymptomatic carriers and children with pharyngitis. 2003 Clin. Infect. Dis. pmid:12856208
Liu H et al. Effect of erythromycin on contractile response of uterine smooth muscle strips in non-pregnant rats. 2003 Jan-Feb Pol J Pharmacol pmid:12856827
Bhattacharya MK et al. Azithromycin in the treatment of cholera in children. 2003 Acta Paediatr. pmid:12856976
Tenson T et al. The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome. 2003 J. Mol. Biol. pmid:12860123
Fisk P An inguinal bubo caused by Mycobacterium chelonae abscessus. 1992 Nov-Dec Int J STD AIDS pmid:1286124
Schöni MH Macrolide antibiotic therapy in patients with cystic fibrosis. 2003 Swiss Med Wkly pmid:12861467
Frean J et al. Susceptibility of Bacillus anthracis to eleven antimicrobial agents including novel fluoroquinolones and a ketolide. 2003 J. Antimicrob. Chemother. pmid:12865385
Mirza S et al. Influence of solvents on the variety of crystalline forms of erythromycin. 2003 AAPS PharmSci pmid:12866939
Deshpande LM and Jones RN Antagonism between penicillin and erythromycin against Streptococcus pneumoniae: does it exist? 2003 Diagn. Microbiol. Infect. Dis. pmid:12867099
Corrêa JC et al. Randomized, open-label, parallel-group, multicenter study of the efficacy and tolerability of IV gatifloxacin with the option for oral stepdown gatifloxacin versus IV ceftriaxone (with or without erythromycin or clarithromycin) with the option for oral stepdown clarithromycin for treatment of patients with mild to moderate community-acquired pneumonia requiring hospitalization. 2003 Clin Ther pmid:12867221
Wolf R et al. Sulfonamide-induced bullous hemorrhagic eruption in a patient with low prothrombin time. 1992 Isr. J. Med. Sci. pmid:1286961
Hergenrother PJ et al. An abiotic strategy for the enantioselective synthesis of erythromycin B. 2003 Angew. Chem. Int. Ed. Engl. pmid:12876743
Vanden Boom TJ Recent developments in the molecular genetics of the erythromycin-producing organism Saccharopolyspora erythraea. 2000 Adv. Appl. Microbiol. pmid:12876795
Syrogiannopoulos GA et al. Antimicrobial susceptibility and macrolide resistance inducibility of Streptococcus pneumoniae carrying erm(A), erm(B), or mef(A). 2003 Antimicrob. Agents Chemother. pmid:12878546
Pai SR et al. In vivo efficacy of the ketolide ABT-773 (cethromycin) against enterococci in a mouse peritonitis model. 2003 Antimicrob. Agents Chemother. pmid:12878548
Crum NF et al. Halting a pneumococcal pneumonia outbreak among United States Marine Corps trainees. 2003 Am J Prev Med pmid:12880877
Schmidt LE et al. Relationship between postoperative erythromycin breath test and early morbidity in liver transplant recipients. 2003 Transplantation pmid:12883193
Peck KR et al. Antimicrobials as potential adjunctive agents in the treatment of biofilm infection with Staphylococcus epidermidis. 2003 Chemotherapy pmid:12886054
Portillo A et al. Clonal diversity among erythromycin-resistant beta-haemolytic Streptococcus isolates in La Rioja, Spain. 2003 J. Antimicrob. Chemother. pmid:12888595
Shishkov N and Drumev D [Possible synergic action of some drug combinations against Mycoplasma gallisepticum]. 1975 Vet Med Nauki pmid:128891
Mercer BM et al. What we have learned regarding antibiotic therapy for the reduction of infant morbidity after preterm premature rupture of the membranes. 2003 Semin. Perinatol. pmid:12889589
Andrews WW and Goldenberg RL What we have learned from an antibiotic trial in fetal fibronectin positive women. 2003 Semin. Perinatol. pmid:12889590
Fietta A et al. Uptake of flurithromycin by human polymorphonuclear phagocytes: partial characterization of the entry mechanism. 1992 Chemotherapy pmid:1288969
Haefeli WE et al. Possible risk for cardiac arrhythmia related to intravenous erythromycin. 1992 Intensive Care Med pmid:1289371
Murli S et al. Metabolic engineering of Escherichia coli for improved 6-deoxyerythronolide B production. 2003 J. Ind. Microbiol. Biotechnol. pmid:12898389
Schlüsener MP et al. Determination of antibiotics from soil by pressurized liquid extraction and liquid chromatography-tandem mass spectrometry. 2003 J Chromatogr A pmid:12899294
Yongge L et al. Relationship between plasma motilin and effect of oral erythromycin on gallbladder contraction in patients of functional dyspepsia. 2000 Chin. Med. Sci. J. pmid:12901646
Huang JQ and Xie CM [The effects of erythromycin on the secretion of tumor necrosis factor-alpha and transforming growth factor-beta1 and expression of connexin 43 in human pleural mesothelial cells]. 2003 Zhonghua Jie He He Hu Xi Za Zhi pmid:12901826
Kuijper EJ et al. Genotypic identification of erythromycin-resistant campylobacter isolates as helicobacter species and analysis of resistance mechanism. 2003 J. Clin. Microbiol. pmid:12904383
Hu Z et al. A specific role of the Saccharopolyspora erythraea thioesterase II gene in the function of modular polyketide synthases. 2003 Microbiology (Reading, Engl.) pmid:12904561
Hankø E et al. Administration of drugs known to inhibit P-glycoprotein increases brain bilirubin and alters the regional distribution of bilirubin in rat brain. 2003 Pediatr. Res. pmid:12904601
Stratchounski LS et al. The inventory of antibiotics in Russian home medicine cabinets. 2003 Clin. Infect. Dis. pmid:12905133
Hanada E et al. Inhibitory effect of erythromycin on potassium currents in rat ventricular myocytes in comparison with disopyramide. 2003 J. Pharm. Pharmacol. pmid:12906757
Pearlman M Prevention of early-onset group B streptococcal disease in newborns. 2003 Obstet Gynecol pmid:12907122
Maravić G et al. Alanine-scanning mutagenesis of the predicted rRNA-binding domain of ErmC' redefines the substrate-binding site and suggests a model for protein-RNA interactions. 2003 Nucleic Acids Res. pmid:12907737
Lemahieu WP et al. Measurement of hepatic and intestinal CYP3A4 and PGP activity by combined po + iv [14C]erythromycin breath and urine test. 2003 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:12909563
Carletti M et al. In vitro formation of metabolic-intermediate cytochrome P450 complexes in rabbit liver microsomes by tiamulin and various macrolides. 2003 Jul-Aug Vet. Res. pmid:12911857
Tack J et al. Assessment of meal induced gastric accommodation by a satiety drinking test in health and in severe functional dyspepsia. 2003 Gut pmid:12912857
Reina J et al. Emergence of resistance to erythromycin and fluoroquinolones in thermotolerant Campylobacter strains isolated from feces 1987-1991. 1992 Eur. J. Clin. Microbiol. Infect. Dis. pmid:1291314
Miyashita N et al. In vitro activity of cethromycin, a novel antibacterial ketolide, against Chlamydia pneumoniae. 2003 J. Antimicrob. Chemother. pmid:12917246
Walsh F et al. High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae. 2003 J. Antimicrob. Chemother. pmid:12917252
Weber K How I treat perioral dermatitis: non-compliance with the treatment guidelines. 2003 Dermatology (Basel) pmid:12920383
Cleary JD et al. Effects of amphotericin B and caspofungin on histamine expression. 2003 Pharmacotherapy pmid:12921242
Ioannidou S et al. In vitro activity of telithromycin (HMR 3647) against Greek Streptococcus pyogenes and Streptococcus pneumoniae clinical isolates with different macrolide susceptibilities. 2003 Clin. Microbiol. Infect. pmid:12925112
Enomoto F et al. Modulation of neutrophil adhesion to vascular endothelial cells in rat experimental otitis media treated with a macrolide. 2003 Auris Nasus Larynx pmid:12927286
Ergin A et al. In vitro susceptibility, tolerance and MLS resistance phenotypes of Group C and Group G streptococci isolated in Turkey between 1995 and 2002. 2003 Int. J. Antimicrob. Agents pmid:12927957
Blandino G et al. Bactericidal activity and postantibiotic effect of cefdinir (Cl 983, FK 482) against selected pathogens. 1992 Drugs Exp Clin Res pmid:1292914
Metaxa-Mariatou V et al. Documentation of Legionella pneumophila and Mycobacterium tuberculosis co-existence in a patient with acute respiratory distress syndrome. 2003 Jul-Aug In Vivo pmid:12929592
Bowers AK et al. Molecular markers for rapidly identifying candidate genes in Chlamydomonas reinhardtii. Ery1 and ery2 encode chloroplast ribosomal proteins. 2003 Genetics pmid:12930744
Ponte C et al. Does acetaminophen interfere in the antibiotic treatment of acute otitis media caused by a penicillin-resistant pneumococcus strain? A gerbil model. 2003 Pediatr. Res. pmid:12930908
Petkovic H et al. A novel erythromycin, 6-desmethyl erythromycin D, made by substituting an acyltransferase domain of the erythromycin polyketide synthase. 2003 J. Antibiot. pmid:12931864
Mikasa K et al. [The 5th report on long-term chemotherapy using erythromycin (EM) for chronic lower airway infection--cases followed over 7 years]. 1992 Kansenshogaku Zasshi pmid:1293219
Cao W et al. [Infectious distribution and resistant of Neisseria gonorrhoeae, Mycoplasma, and Chlamydia trachomatis in the chronic prostatitis]. 2003 Hunan Yi Ke Da Xue Xue Bao pmid:12934372
Giovanetti E et al. Presence of the tet(O) gene in erythromycin- and tetracycline-resistant strains of Streptococcus pyogenes and linkage with either the mef(A) or the erm(A) gene. 2003 Antimicrob. Agents Chemother. pmid:12936983
George A and Rubin G A systematic review and meta-analysis of treatments for impetigo. 2003 Br J Gen Pract pmid:12939895
Okubo T et al. [Antimicrobial activities of macrolides against recent clinical isolates, and analysis of resistant mechanisms]. 2003 Jpn J Antibiot pmid:12942787
Sekiguchi J et al. Spread of erythromycin-, tetracycline-, and aminoglycoside-resistant genes in methicillin-resistant Staphylococcus aureus clinical isolates in a Kumamoto Hospital. 2003 Jpn. J. Infect. Dis. pmid:12944686
Li F et al. [An experimental study of gastric pacing on postsurgical gastric dynamic dysfunction]. 2003 Sichuan Da Xue Xue Bao Yi Xue Ban pmid:12947728
Sharp JS and Bechhofer DH Effect of translational signals on mRNA decay in Bacillus subtilis. 2003 J. Bacteriol. pmid:12949089
Veronese ML et al. Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice. 2003 J Clin Pharmacol pmid:12953340
Janssen LJ and Wattie J Electrophysiological effects of erythromycin, but lack of mechanical effects, in airway smooth muscle. 2003 Eur. J. Pharmacol. pmid:12954364
Dehouck P et al. Analysis of erythromycin and benzoylperoxide in topical gels by liquid chromatography. 2003 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:12954380
Baier RJ et al. Failure of erythromycin to eliminate airway colonization with ureaplasma urealyticum in very low birth weight infants. 2003 BMC Pediatr pmid:12956892
Zhang L et al. P-glycoprotein restricted transport of nimodipine across blood-brain barrier. 2003 Acta Pharmacol. Sin. pmid:12956939
Baquero F and Reig M Resistance of anaerobic bacteria to antimicrobial agents in Spain. 1992 Eur. J. Clin. Microbiol. Infect. Dis. pmid:1295754
Qin XY et al. Involvement of dopamine D3 and neuropeptide Y Y5 receptors in diabetic gastroparetic rats without response to erythromycin. 2003 Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao pmid:12958653
ElHennawy AA et al. Erythromycin fails to improve feeding outcome in feeding-intolerant preterm infants. 2003 J. Pediatr. Gastroenterol. Nutr. pmid:12960650
Cook MA et al. Uptake of erythromycin by first-feeding sockeye salmon, Oncorhynchus nerka (Walbaum), fed live or freeze-dried enriched adult Artemia or medicated pellets. 2003 J. Fish Dis. pmid:12962236
Oriabinskaia LB et al. [Energy metabolism in Staphylococci containing plasmids of resistance to a number of antibiotics]. 1992 Antibiot. Khimioter. pmid:1296533
Grigor'ev AE et al. [Construction of hybrid plasmids containing genes for erythromycin biosynthesis and amplifying sequence AUD-Sr1 of Streptomyces rimosus]. 1992 Antibiot. Khimioter. pmid:1296539
Alvarado A and Flores ME Characterization and regulation of NADP+-isocitrate dehydrogenase from Saccharopolyspora erythraea. 2003 Biotechnol. Lett. pmid:12967008
Boivin M et al. Motilin and the postprandial motility of the antrum. 1992 Can. J. Physiol. Pharmacol. pmid:1296862
Solladié-Cavallo A et al. erythro-1-Naphthyl-1-(2-piperidyl)methanol: synthesis, resolution, NMR relative configuration, and VCD absolute configuration. 2003 J. Org. Chem. pmid:12968880
Volokhov D et al. Microarray analysis of erythromycin resistance determinants. 2003 J. Appl. Microbiol. pmid:12969293
Sugihara E et al. Macrolide antibiotics directly reduce active oxygen generation by neutrophils in human peripheral blood. 2003 Kurume Med J pmid:12971257
Hoogmartens J Liquid chromatography for the quantitative analysis of antibiotics--some applications using poly(styrene-divinylbenzene). 1992 Oct-Dec J Pharm Biomed Anal pmid:1298392
ERYTHROMYCIN. 1952 Br Med J pmid:12987755
ANDERSON RC et al. The toxicity and distribution of ilotycin. 1952 J Am Pharm Assoc Am Pharm Assoc pmid:12999613
Bavoux F [Torsades de pointes and anti-infective agents]. 1992 Sep-Oct Therapie pmid:1299973
Petrova MS et al. [Antibiotic therapy in children with pertussis]. 1992 Antibiot. Khimioter. pmid:1300936
Shi XZ and Zhang JJ [Erythromycin: a motilin receptor agonist]. 1992 Sheng Li Ke Xue Jin Zhan pmid:1302371
Lum L and Ngeow YF Chlamydia pneumoniae respiratory infection in a child--a case report. 1992 Med. J. Malaysia pmid:1303485
DEARING WH Micrococcic (staphylococcic) enteritis as a complication of antibiotic therapy; its response to erythromycin. 1953 Proc Staff Meet Mayo Clin pmid:13037897
Song JF et al. [Resistant rate to antibiotics in Tian Tan Hospital for 3 years]. 1992 Zhonghua Nei Ke Za Zhi pmid:1303851
NEW antibiotic. 1953 South. Med. J. pmid:13038549
Leelarasamee A and Leelarasamee I Comparative efficacy of spiramycin and erythromycin in acute exudative tonsillitis in adults: a randomized controlled trial. 1992 J Med Assoc Thai pmid:1304021
MCCOWEN MC et al. The effects of erythromycin (ilotycin, lilly) against certain parasitic organisms. 1953 Am. J. Trop. Med. Hyg. pmid:13040654
HAIGHT TH and FINLAND M The antibacterial action of erythromycin. 1952 Proc. Soc. Exp. Biol. Med. pmid:13047351
FREEMAN LC and SCOTT RB Erythromycin in treatment of pyoderma in children. 1953 J. Pediatr. pmid:13053367
VANNUCCHI V [Clinical study of a new antibiotic; erythromycin]. 1952 Riv Crit Clin Med pmid:13056483
NESERKE EI Clinical report on the new antibiotic, erythromycin. 1953 J. Am. Vet. Med. Assoc. pmid:13061363
Ramirez JA et al. Bactericidal activity of imipenem compared to erythromycin against intracellular Legionella pneumophila. 1992 Drugs Exp Clin Res pmid:1306151
Wang BF [A clinical study of 50 cases of Legionnaires disease]. 1992 Zhonghua Jie He He Hu Xi Za Zhi pmid:1306405
GABLE GR et al. Treatment of gonorrhea with erythromycin. 1953 Am J Syph Gonorrhea Vener Dis pmid:13065617